| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
36 companies
Orbimed Advisors LLC is a Director, 10% Owner at Edgewise Therapeutics, Inc. with holdings across 36 companies. Recent SEC Form 4 filings include 7 buys and 15 sells.
Estimated insider holdings value: $2043.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2021 | EWTX Edgewise Therapeutics, Inc. | Director, 10% Owner | Buy | 359,375 | $16.00 | $5,750,000.00 | +2.7% | -23.8% | -70.3% | |
| Mar 30, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 103,424 | $23.48 | $2,428,092.22 | -2.3% | -23.8% | -77.0% | |
| Mar 26, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 112,298 | $24.53 | $2,754,247.38 | -1.6% | -23.6% | -80.9% | |
| Mar 23, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 32,940 | $26.21 | $863,339.00 | -0.4% | -21.5% | -78.6% | |
| Mar 18, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 66,202 | $27.95 | $1,850,338.63 | -0.9% | -29.1% | -74.7% | |
| Mar 15, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 238,282 | $30.54 | $7,275,985.53 | -2.9% | -30.5% | -78.4% | |
| Feb 17, 2021 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 1,285,714 | $3.50 | $4,499,999.00 | +19.0% | - | - | |
| Feb 9, 2021 | TERN Terns Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 475,000 | $17.00 | $8,075,000.00 | +14.3% | - | - | |
| Dec 8, 2020 | SPRY Ars Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 1,190,477 | $21.00 | $25,000,017.00 | +442.0% | - | - | |
| Dec 8, 2020 | WHWK Whitehawk Therapeutics, Inc. | 10% Owner | Sell | 21,400 | $1.96 | $41,944.00 | -100% | - | - |